首页> 中文期刊> 《中国药房》 >第1批OTC中成药不良反应文献分析

第1批OTC中成药不良反应文献分析

         

摘要

目的:探讨OTC中成药的不良反应发生情况,指导合理用药。方法:对国内40年(1960年~2000年)公开报道的116例(次)中成药诱发ADRs进行分析。结果:诱发ADRs的药物涉及34个品种,其中以藿香正气水19例(次)为最多,其次是风油精16例(次),三七片13例(次),这3种药引起的ADRs占41.4%。ADRs类型以过敏反应占的比例最大(67.2%),116例中115例治愈(99.1%),1例死亡。结论:OTC中成药也存在不良反应,广大消费者应引起注意,同时也应消除恐慌心理,只要用药得当,OTC中成药的ADRs发生率很低,且愈后较好。%OBJECTIVE: To review the ARDs of ready-made Chinese drugs included in OTC list .METHODS: 160 cases of ARDs induced by ready-made Chinese drugs, reported in Chinese journals over 40 years(1960~2000), were analysed .RESULTS: 34 kinds of drugs were involved in inducing ARDs, of which, Huoxiang Zhengqi liquid was the most common one( 19 cases), essense of Fengyou and pseudo-ginseng tablet were the next(16 cases and 13 cases respectively).The ARDs in duced by above-mentioned 3 drugs accounted for 41.4% of total ARDs.Hypersensitive reaction was the most common ARD (67.2%) . 115 of 116 cases were cured, one died.CONCLUSION: Ready-made Chinese drugs can induce ARDs, so the consumers should pay attention to it, however,they need not feel frieghtened,so long as the drugs are used rationally, the incidence of ARDs is very low and the prognosis is good.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号